The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease	Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Huntington disease, basal ganglia disorder, brain disorder, central nervous system disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder	Recruiting	Phase 2	2025-03-19		NCT06853743

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Elysium Health	7
Haukeland University Hospital	163
Klinbeforsk	8
NKS Olaviken Gerontopsychiatric Hospital	3
Oslo University Hospital	327
South-Eastern Norway Regional Health Authority	22
The Dam Foundation	12

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Oslo University Hospital	Oslo	Norway	13